Pepdox
Studies
Peptides
Calculator
Semaglutide for Weight Reduction in Type 1 Diabetes: Promising Results With Uncertain Glycemic Impact. | Pepdox
Home
/
Search
/
PMID 39655368
Semaglutide for Weight Reduction in Type 1 Diabetes: Promising Results With Uncertain Glycemic Impact.
Journal of diabetes science and technology
2025
PMID: 39655368
View on PubMed
DOI: 10.1177/19322968241304779
Semaglutide
Authors
Orrange, Sharon; Humphrey, Tess; Fayne, Ethan; Peters, Anne
Keywords
GLP-1 receptor agonists in T1D
glycemic control and insulin therapy
obesity in type 1 diabetes
semaglutide and weight loss